Dr Reddy’s Lab shares hit 52-week low after Q1 profit falls 69%, brokerages cut targets

Citi retains its sell call with a target price of ₹1,040, and BofA retains its accumulate recommendation with a target price of ₹1,480, compared with an earlier target of ₹1,500

Raccontata dathehindubusinessline.comeconomictimes.indiatimes.com